Technology | November 17, 2011

PenRad Expands MIS By Offering Integrations With Volpara Breast Density Software

November 17, 2011 – PenRad announced it is offering customers access to a new integration within its mammography information system (MIS): Volpara Breast Density Software for automatic quantification of breast density and volume. This integration offers PenRad MIS users access to further streamline workflow and improve patient care management.

Volpara automatically quantifies breast density and volume, and provides physicians with automatic and objective quantitative breast tissue density information. It can be used in informing patients of their tissue density-related risk and in documenting the need for adjuvant screening

A national trend has been developing to incorporate laws requiring breast imaging programs to notify patients of breast density following a mammogram. Dense breast tissue has been shown to obscure abnormalities on a mammogram.

Connecticut and Texas have passed breast density laws, and several other states have related legislation pending. These new laws indicate that upon completion of a mammogram, if dense breast tissue is demonstrated, patients may benefit from adjunct screening tests (i.e. ultrasound, magnetic resonance imaging) to assist in identifying abnormalities.

“PenRad shares our commitment to improving the detection of cancer through better access to critical breast health information,” said Ralph Highnam, M.D., CEO at Matakina International Ltd. “The objective measurement of breast density clearly offers important clinical information, but the technology will not be used effectively unless it is easily integrated into routine diagnostic workflow. The ability to display breast density values on the PenRad MIS is a significant step.”

PenRad products include a Web-based multimodality reading workstation; computer-aided analysis for magnetic resonance imaging (MRI) and computer-aided detection (CAD) for ultrasound; and information systems for fast and reliable interpretation, reporting, tracking and management of clinical data.

For more information: www.penrad.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
Computer Error Leads to 450,000 Missed U.K. Breast Screening Invites
News | Mammography | May 02, 2018
Since 2009, approximately 450,000 women around age 70 in the United Kingdom did not receive final breast screening...
Pilot Study Initiated for Blood-Based Breast Test
News | Oncology Diagnostics | May 01, 2018
Overlake Medical Center in Bellevue, Wash., announced it has enrolled 85 patients in a pilot study of a blood test to...
Overlay Init